(Date:7/3/2009)..., SHANGHAI, July 3 /PRNewswire-Asia/ -- Sundia...d biotech R&D outsourcing company in Shanghai,...n appointed Senior Vice,President of Chemistry Se... worked at Neurocrine Biosciences, a drug,discove...5 years, from a staff,scientist to Senior Directo...
(Date:7/3/2009)... A new urine drug test kit ...ng solution for individuals that want a fast and a...mpany Confirm BioSciences, the cup has a sleek, in...echnology. It’s also very competitively pric...re currently being sold on the market , ...
(Date:7/3/2009)... ReverseAges.com launches n... pressure, adrenal fatigue, and how to best deal w... San Diego, CA (PRWEB) July 3, 2009 -- ReverseAge... These pages explain the dangers of common health ...ssure is caused by a variety of factors, and the n...
(Date:7/3/2009)... Julian Whitaker, MD, a fou...featured expert on searchjointpain.com, a new info... and muscle conditions and solutions. , ... Julian Whitaker, MD, a founder of the alternative...chjointpain.com, a new informational Web site devo...
Breaking Medicine News(10 mins):Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2...h former chief ministers of Bihar, have found a ne... disciple// of popular guru Ramdev. Sources in Lal...s suffering from stress after the loss in the Biha...ember. Senior RJD leader Anwar Ahmad, a close asso...
...vernment to donate nearly 100 acres of land to gur....// The yoga guru has also been invited to set up ...dic medicine preparations using the abundant state...ernment is likely to sign a memorandum of understa...
...y that Aspartame can cause lymphoma, leukaemia. Th...unce bottles of diet soda sweetened with aspartame...udy would be published in March issue of Environme... US government-run environmental science journal. ...
...serves to be called the only health care center in...S) for all kinds of surgeries. // Thanks to the 4 ...magnification of a specific body part on the scree...er, cardiac bypass, surgical excision of brain tum...
Other Medicine News:Health News:Any Form Of Minimally Invasive Surgery- Name It & They Do It! 2(Date:6/28/2009)...rtugal, June 29 Data presented,to...nt with the novel,once-daily anti-epileptic Zebi...n a marked and sustained decrease in seizure frequ...the one-year extension of a pivotal Eslicarbazepin...nternational Congress for Epilepsy in,Budapest, H...
(Date:6/26/2009)...RNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT...f data associated with a retrospective follow-up o...ta clearly show that no definitive conclusions can... between Lantus(R) (insulin glargine [rDNA] inject...e authors of the study point out. , , Clinical ...
(Date:6/26/2009)...pproval of New Anti-TNF Therapy in Three Rheumatic... , HORSHAM, Pa. and KENILWORTH, N.J., June 26 /P.... and Schering-Plough Corporation (NYSE: SGP ) a...oducts for Human Use (CHMP) of the European Medici...mending the approval of SIMPONI(TM) (golimumab) as...
(Date:6/25/2009)...ewswire/ -- "Congratulations President Obama on yo...o cut prescription costs for the elderly," says Ma... "We thought you should know that you have a littl...soriasis sufferers of all ages." , , Mr. Steele...e submission of their findings from a recent clini...
Breaking Medicine Technology:Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center 1953 1Digital Healthcare Announces Cincinnati Eye Institute is Latest Retasure Reading Center 1953 2Brilliant perspectives 1337 1Brilliant perspectives 1337 2Brilliant perspectives 1337 3Defibrillators Not Dangerous While Driving 6933 1Defibrillators Not Dangerous While Driving 6933 2Defining the Value of Medicine in an Evidence Based Healthcare Marketplace 6930 1Defining the Value of Medicine in an Evidence Based Healthcare Marketplace 6930 2Defining the Value of Medicine in an Evidence Based Healthcare Marketplace 6930 3... 2007 /PRNewswire-FirstCall/,- OncoGenex Technolog...unced that preliminary data from ongoing clinical ...an Society of Clinical,Oncology Annual Meeting (AS...II clinical study of OGX-011 in hormone refractory...al study of,OGX-011 in non-small cell lung cancer....
... in Lipoprotein Lipase,Deficiency Established , Am...m Molecular,Therapeutics (AMT), a leader in the fi... I/II clinical trial results with its lead,product...Lipoprotein Lipase (LPL) deficient patients at the...ne Therapy (ASGT) in Seattle.,The study,s lead inv...
Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4Ideal for satellite clinics or for those seeking high quality with high value, the Debut stand is an economical, full-function instrument-delivery system. Its steel construction and molded composite
The Encore Stand combines the proven mechanical structure and durability of the popular Deluxe Stand, with a modern, sophisticated appearance.
The Marco Encore Chair continues the Marco tradition of useful features and unsurpassed quality. Its attractive, modern look blends beautifully with any office decore.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: